- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05967637
The Effect of Whole-Body Vibration Treatment Before Total Knee Arthroplasty
July 8, 2025 updated by: Sevim Beyza Ölmez, Gazi University
The study's objective is to investigate the effects of whole-body vibration therapy administered before surgery on various factors related to patients who undergo total knee arthroplasty.
These factors include pain, swelling, skin temperature, normal joint movement, knee joint position sense, knee extensor muscle strength, functional status, and patient satisfaction.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The study will include participants aged 50-80 who are planning to undergo total knee arthroplasty.
According to the sample size analysis, a total of 40 people will be included in this study.
The enrolled participants will be randomly assigned to one of two parallel groups: the whole-body vibration group or the sham whole-body vibration group.
Both groups will receive standard patient education and exercise training.The experimental group will receive whole-body vibration along with exercise on the whole-body vibration device, while the control group (sham group) will receive sham vibration on the same device.
All participants will receive treatment for a total of 5 days, one session per day.
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06490
- Gazi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with advanced idiopathic knee OA and scheduled for unilateral total knee arthroplasty will be considered candidates for the present study and will be asked to participate
Exclusion Criteria:
- if they had undergone another hip or knee joint replacement in the previous year
- if they had any medical condition in which exercise was contraindicated
- if they had any disease that affected functional performance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Whole-body vibration
Standard patient education and exercise training + whole body vibration
|
The vibration will be applied for 10 minutes (30 seconds rest, 30 seconds training, 10 reps) in total with a low frequency (20 HZ) and low amplitude (2mm).
Participants will be asked to stand in a squatting position by semi-flexing (30°) their knees during the 30-second vibration period.
|
|
Sham Comparator: Sham-whole-body vibration
Standard patient education and exercise training + sham whole body vibration
|
The sham-whole body vibration treatment will follow the same procedures with the vibration machine off.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline pain severity
Time Frame: baseline
|
The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.
|
baseline
|
|
Change in pain severity from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.pain and 10 representing maximal pain.
|
up to 5 days after baseline
|
|
Change in the preoperative pain severity on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.
|
up to 7 days after surgery
|
|
Change in pain severity from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.
|
up to 14 days after surgery
|
|
Change in pain severity from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.
|
up to 21 days after surgery
|
|
Baseline leg circumference
Time Frame: baseline
|
Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.
|
baseline
|
|
Change in leg circumference from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.
|
up to 5 days after baseline
|
|
Change in the preoperative leg circumference on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.
|
up to 7 days after surgery
|
|
Change in leg circumference from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.
|
up to 14 days after surgery
|
|
Change in leg circumference from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.
|
up to 21 days after surgery
|
|
Baseline range of motion
Time Frame: baseline
|
The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.
|
baseline
|
|
Change in range of motion from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.
|
up to 5 days after baseline
|
|
Change in the preoperative range of motion on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.
|
up to 7 days after surgery
|
|
Change in range of motion from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.
|
up to 14 days after surgery
|
|
Change in range of motion from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.
|
up to 21 days after surgery
|
|
Baseline muscle strength
Time Frame: baseline
|
Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.
|
baseline
|
|
Change in muscle strength from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.
|
up to 5 days after baseline
|
|
Change in the preoperative muscle strength on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.
|
up to 7 days after surgery
|
|
Change in muscle strength from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.
|
up to 14 days after surgery
|
|
Change in muscle strength from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.
|
up to 21 days after surgery
|
|
Baseline skin temperature
Time Frame: baseline
|
A portable infrared thermometer will be used to measure knee skin temperature.
|
baseline
|
|
Change in skin temperature from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
A portable infrared thermometer will be used to measure knee skin temperature.
|
up to 5 days after baseline
|
|
Change in the preoperative skin temperature on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
A portable infrared thermometer will be used to measure knee skin temperature.
|
up to 7 days after surgery
|
|
Change in skin temperature from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
A portable infrared thermometer will be used to measure knee skin temperature.
|
up to 14 days after surgery
|
|
Change in skin temperature from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
A portable infrared thermometer will be used to measure knee skin temperature.
|
up to 21 days after surgery
|
|
Baseline knee proprioception
Time Frame: baseline
|
Active reposition test will be measured using a digital inclinometer device.
|
baseline
|
|
Change in knee proprioception from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
Active reposition test will be measured using a digital inclinometer device.
|
up to 5 days after baseline
|
|
Change in the preoperative knee proprioception on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
Active reposition test will be measured using a digital inclinometer device.
|
up to 7 days after surgery
|
|
Change in knee proprioception from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
Active reposition test will be measured using a digital inclinometer device.
|
up to 14 days after surgery
|
|
Change in knee proprioception from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
Active reposition test will be measured using a digital inclinometer device.
|
up to 21 days after surgery
|
|
Baseline Time Up and Go
Time Frame: baseline
|
functional performance test
|
baseline
|
|
Change in Time Up and Go from baseline to day 5 after interventions
Time Frame: up to 5 days after baseline
|
functional performance test
|
up to 5 days after baseline
|
|
Change in the preoperative Time Up and Go on the 7th day of surgery
Time Frame: up to 7 days after surgery
|
functional performance test
|
up to 7 days after surgery
|
|
Change in Time Up and Go from day 7 to day 14 post-surgery
Time Frame: up to 14 days after surgery
|
functional performance test
|
up to 14 days after surgery
|
|
Change in Time Up and Go from day 14 to day 21 post-surgery
Time Frame: up to 21 days after surgery
|
functional performance test
|
up to 21 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF-36
Time Frame: baseline
|
The 36-Item Short-Form Health Survey (SF-36) is a general scoring instrument used to provide a health profile comprised of eight scaled scores.
Each scale is instantly turned into a 0-100 scale, allowing identification of the patient's physical and mental status.
A higher score means a better result.
|
baseline
|
|
Change in the preoperative SF-36 on the 21st day of surgery
Time Frame: up to 21 days after surgery
|
The 36-Item Short-Form Health Survey (SF-36) is a general scoring instrument used to provide a health profile comprised of eight scaled scores.
Each scale is instantly turned into a 0-100 scale, allowing identification of the patient's physical and mental status.
A higher score means a better result.
|
up to 21 days after surgery
|
|
WOMAC
Time Frame: before interventions, 21st day after surgery
|
The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a disease-specific self-report multidimensional questionnaire that assesses pain, stiffness, and physical functional disability.
A higher score means a better result.
|
before interventions, 21st day after surgery
|
|
Change in the preoperative WOMAC on the 21st day of surgery
Time Frame: up to 21 days after surgery
|
The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a disease-specific self-report multidimensional questionnaire that assesses pain, stiffness, and physical functional disability.
A higher score means a better result.
|
up to 21 days after surgery
|
|
Global Rating of Change Scales (GROC)
Time Frame: up to 21st day after surgery
|
The GROC score, which has seven response options ranging from 'much worse' (a score of 0) to 'much better' (a score of six), will be used to determine the subject's perception of overall improvement.
|
up to 21st day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Sevim Beyza Ölmez, Gazi University
- Study Director: Zeynep Hazar, Gazi University
- Study Chair: Cemil Yıldız, Gulhane Training and Research Hospital
- Principal Investigator: Beyza Yazgan, Gazi University
- Principal Investigator: İnci Ayaş, Gazi University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Actual)
August 1, 2024
Study Completion (Actual)
October 1, 2024
Study Registration Dates
First Submitted
July 11, 2023
First Submitted That Met QC Criteria
July 29, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Actual)
July 11, 2025
Last Update Submitted That Met QC Criteria
July 8, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-874
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthropathy of Knee
-
Universidad de ZaragozaCompletedArthropathy of Knee | Arthropathy of HipSpain
-
Centre Hospitalier Universitaire de la RéunionCompletedArthropathy of Knee | Arthropathy of HipRéunion
-
Super Inspired LLCRecruitingArthropathy of Knee | Arthropathy of HipUnited States
-
Medical University of South CarolinaCompletedArthropathy of Knee | Arthropathy of HipUnited States
-
Hvidovre University HospitalCompletedArthropathy of Knee | Arthropathy of HipDenmark
-
Hôpital Privé SévignéActive, not recruitingArthropathy of Knee | Arthropathy of HipFrance
-
Diskapi Teaching and Research HospitalCompletedArthropathy of Knee | Arthropathy of HipTurkey
-
Stryker OrthopaedicsActive, not recruitingKnee Arthritis | Arthropathy of Knee | ReplacementUnited States
-
University of PennsylvaniaSuspendedArthropathy of Knee Joint | Arthropathy of Hip JointUnited States
-
Ohio State UniversityTerminatedArthropathy of Knee | Opioid Use | Arthropathy of HipUnited States
Clinical Trials on Whole body vibration
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
The Hong Kong Polytechnic UniversityCompleted
-
The Hong Kong Polytechnic UniversityUnknown
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of the Balearic IslandsUnknown
-
Cairo UniversityRecruitingOverweight , ObesitySaudi Arabia
-
Cairo UniversityCompletedObesity | OverweightSaudi Arabia
-
Cairo UniversityNot yet recruitingQuality of Life | Balance | Chemotherapy Induced Peripheral Neuropathy (CIPN) | Fall Risk, Fall Prevention | Whole Body Vibration
-
Uludag UniversityNot yet recruiting